Asymptomatic factor VII deficiency in African Americans

American Journal of Clinical Pathology

Volumn 126, Issue 1, 2006, Pages 128-132

  Pollak, Eleanor S ^a,e   Russell, Theresa T ^b   Ptashkin, Beverly ^a   Smith Whitley, Kim ^c   Camire, Rodney M ^c   Bauer, Kenneth A ^d  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b Department of Environmental and Radiological Health Sciences   (United States)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Blood banking; Clinical pathology; Coagulation; Molecular diagnostics; Transfusion medicine

Indexed keywords

ADENINE NUCLEOTIDE; AMINO ACID; ARGININE; BLOOD CLOTTING FACTOR 7; GLUTAMINE; GUANINE NUCLEOTIDE; THROMBOPLASTIN;

ADOLESCENT; ADULT; AFRICAN AMERICAN; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING FACTOR 7 DEFICIENCY; BLOOD TRANSFUSION; CLINICAL ARTICLE; CLINICAL LABORATORY; CONTROLLED STUDY; FEMALE; HUMAN; LABORATORY TEST; MALE; POINT MUTATION; PRIORITY JOURNAL; PROTHROMBIN TIME; RABBIT; SCHOOL CHILD;

EID: 33745774573     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/36HQ36ETU7K8MUXT     Document Type: Article

References (23)

1. Morrissey JH. Tissue factor: an enzyme cofactor and a true receptor. Thromb Haemost. 2001;6:66-74.
2. O'Hara PJ, Grant FJ, Haldeman BA, et al. Nucleotide sequence of the gene coding for human factor VII, a vitamin K-dependent protein participating in blood coagulation. Proc Natl Acad Sci U S A. 1987;84:5158-5162.
3. Mariani GM, Herrmann FH, Dolce A, et al. Clinical phenotypes and factor VII genotype in congenital factor VII deficiency. Thromb Haemost. 2005;93:481-487.
4. Perry DJ. Factor VII deficiency. Blood Coagul Fibrinolysis. 2003;14:S47-S54.
5. Girolami A, Fabris F, Dal Bo Zanon R, et al. Factor VII Padua: a congenital coagulation disorder due to an abnormal factor VII with a peculiar activation pattern. J Lab Clin Med. 1978;91:387-395.
6. Girolami A, Vettore S, Bortoletto E, et al. Mild factor VII deficiency due to heterozygosis is not associated with a bleeding tendency [letter]. Blood Coagul Fibrinolysis. 2005;16:459-460.
7. James HL, Girolami A, Hubbard JG, et al. The dysfunction of coagulation factor VIIPadua results from substitution of arginine-304 by glutamine. Biochim Biophys Acta. 1993;1172:301-305.
8. O'Brien DP, Gale KM, Anderson JS, et al. Purification and characterization of factor VII 304-Gln: a variant molecule with reduced activity isolated from a clinically unaffected male. Blood. 1991;78:132-140.
9. Triplett DA, Brandt JT, Batard MA, et al. Hereditary factor VII deficiency: heterogeneity defined by combined functional and immunochemical analysis. Blood. 1985;66:1284-1287.
10. Chaing S, Clarke B, Sridhara S, et al. Severe factor VII deficiency caused by mutations abolishing the cleavage site for activation and altering binding to tissue factor. Blood. 1994;83:3524-3535.
11. Furlan Freguia C, Toso R, Pollak ES, et al. Characterization of mild coagulation factor VII deficiency: activity and clearance of the Arg315Trp and Arg315Lys variants in the Cys310-Cys329 loop (c170s). Haematologica. 2004;89:1504-1509.
12. McVey JH, Boswell E, Mumford AD, et al. Factor VII deficiency and the FVII mutation database. Hum Mutat. 2001;17:3-17.
13. Krauss JS, Matthews A, Oliver J, et al. African-American factor VII-deficient variants in Georgia (FVII variants). Am J Hematol. 1994;47:239-241.
14. Barnett JM, Demel KC, Mega AE, et al. Lack of bleeding in patients with severe factor VII deficiency. Am J Hematol. 2005;78:134-137.
15. Takamiya O, Funahashi S, Kinoshita S, et al. Factor VII activity and antigen in a patient with abnormal factor VII. Clin Lab Haematol. 1988;10:159-165.
16. Tuddenham EG, Pemberton S, Cooper DN. Inherited factor VII deficiency: genetics and molecular pathology. Thromb Haemost. 1995;74:313-321.
17. Rodrigues DN, Siqueira LH, Galizoni AM, et al. Prevalence of factor VII deficiency and molecular characterization of the F7 gene in Brazilian patients. Blood Coagul Fibrinolysis. 2003;14:289-292.
18. Ketterling RP, Vielhaber E, Sommer SS. The rates of G:C→T:A and G:C→C:G transversions at CpG dinucleotides in the human factor IX gene. Am J Hum Genet. 1994;54:831-835.
19. Dickinson CD, Kelly CR, Ruf W. Identification of surface residues mediating tissue factor binding and catalytic function of the serine protease factor VIIa. Proc Natl Acad Sci U S A. 1996;93:14379-14384.
20. Furlan Freguia C, Toso R, Pinotti M, et al. Comparison among natural (Arg304Gln, Arg304Trp) and artificial (Arg290His, Arg290Lys) mutations in coagulation factor VII loops. J Thromb Haemost. 2003;1:2455-2457.
21. Banner DW, D'Arcy A, Chene C, et al. The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor. Nature. 1996;380:41-46.
22. Roberts HR, Escobar MA. Inherited disorders of prothrombin conversion. In: Colman R, Marder VJ, Clowes AW, et al, eds. Hemostosis and Thrombosis: Basic Principles and Clinical Practice. 5th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2006:928-930.
23. Cohen LJ, McWilliams NB, Neuberg R, et al. Prophylaxis and therapy with factor VII concentrate (human) immuno, vapor heated in patients with congenital factor VII deficiency: a summary of case reports. Am J Hematol. 1995;50:269-276.